SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-002240
Filing Date
2020-01-07
Accepted
2020-01-07 16:09:06
Documents
2
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1635
2 POA DOCUMENT poa.txt EX-24.3_887584 3628
  Complete submission text file 0001209191-20-002240.txt   6743
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK RD, SUITE 220 SAN DIEGO CA 92121
Business Address
FLOWERS KIRSTEN (Reporting) CIK: 0001797209 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37620 | Film No.: 20513411